CEMI

Chembio Diagnostics News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Chembio Diagnostics Inc CEMI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.08 -3.28% 2.36 19:59:35
Open Price Low Price High Price Close Price Prev Close
2.37 2.29 2.3893 2.34 2.44
more quote information »

Recent News

Date Time Source Heading
10/21/202116:50GLOBEChembio Diagnostics to Report Third Quarter 2021 Financial..
10/18/202116:31EDGARCurrent Report Filing (8-k)
9/22/202108:00GLOBEChembio Announces EUA Submission for DPP Respiratory Antigen..
8/27/202111:06SEEKNeuroMetrix, Reneo Pharmaceuticals leads healthcare gainers;..
8/27/202108:00GLOBEChembio Launches Commercial Distribution of Third-Party..
8/09/202116:58EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
8/05/202116:32EDGARCurrent Report Filing (8-k)
8/05/202116:05GLOBEChembio Diagnostics Reports Second Quarter 2021 Financial..
7/22/202117:03GLOBEChembio Diagnostics to Report Second Quarter 2021 Financial..
7/22/202113:03SEEKChembio Diagnostics gets $4M HIV test purchase order
7/22/202112:49GLOBEChembio Diagnostics Receives $4 Million HIV Test Purchase..
7/22/202110:00SEEKNeuroMetrix stock joins Reddit-driven rally with 60% rise in..
7/22/202102:53TRMNChembio Diagnostics Bags $28.3M Oder for SARS-CoV-2 Antigen..
7/21/202108:12SEEKChembio surges on purchase order for COVID—19 antigen test..
7/21/202106:04EDGARCurrent Report Filing (8-k)
7/20/202122:56GLOBEChembio Diagnostics Receives $28.3 Million Purchase Order..
7/19/202117:29EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
7/19/202117:14EDGARCurrent Report Filing (8-k)
7/12/202108:30EDGARAmended Statement of Ownership (sc 13g/a)
6/25/202117:21EDGARCurrent Report Filing (8-k)
6/10/202116:06EDGARCurrent Report Filing (8-k)
5/13/202109:27EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/13/202109:26EDGARProxy Statement (definitive) (def 14a)
5/07/202106:10EDGARNotice of Effectiveness (effect)
5/06/202117:29EDGARQuarterly Report (10-q)
5/06/202116:30EDGARCurrent Report Filing (8-k)
5/06/202116:28SEEKChembio Diagnostics EPS beats by $0.10, beats on revenue
5/06/202116:05GLOBEChembio Diagnostics Reports First Quarter 2021 Financial..
4/30/202117:04EDGARAmended Annual Report (10-k/a)
4/22/202108:00GLOBEChembio Diagnostics to Report First Quarter 2021 Financial..
4/05/202110:28SEEKChembio announces U.S. launch of point-of-care-test to..
4/01/202117:30GLOBEChembio Announces U.S. Commercial Launch of Diagnostic Tool..
3/15/202106:33EDGARSecurities Registration Statement (simplified Form) (s-3)
3/12/202117:24EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/11/202117:23EDGARAnnual Report (10-k)
3/11/202116:21SEEKChembio Diagnostics EPS misses by $0.07, beats on revenue
3/11/202116:05GLOBEChembio Diagnostics Reports Fourth Quarter and Full Year..
3/08/202117:29EDGARInitial Statement of Beneficial Ownership (3)
3/08/202108:34EDGARCurrent Report Filing (8-k)
3/08/202108:00GLOBEChembio Diagnostics Appoints Industry Leader David Bespalko..
2/25/202116:05GLOBEChembio Diagnostics to Report Fourth Quarter and Full Year..
2/16/202112:34EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202110:48EDGARStatement of Ownership (sc 13g)
2/02/202115:18EDGARStatement of Ownership (sc 13g)
1/14/202107:00GLOBEChembio Diagnostics Announces CE Mark for DPP SARS-CoV-2..
12/18/202009:24EDGARStatement of Changes in Beneficial Ownership (4)
12/18/202009:22EDGARInitial Statement of Beneficial Ownership (3)
12/17/202017:15EDGARCurrent Report Filing (8-k)
12/17/202016:05GLOBEChembio Diagnostics Appoints David Acheson, M.D. to its..
12/04/202006:05EDGARCurrent Report Filing (8-k)
See more news about this stock »
Your Recent History
NASDAQ
CEMI
Chembio Di..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211024 11:56:22